Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has shared the schedule of upcoming meetings with analysts and institutional investors, as required by SEBI listing rules. On August 21, 2025, the company will hold one-on-one meetings with Shikhara Investment Management (Singapore) and Axis Mutual Fund. On August 26, 2025, it will meet with JM Financial Institutional Securities Ltd. The company has noted that this schedule may change due to unforeseen reasons. The intimation was signed by the Company Secretary & Compliance Officer.
This is a routine disclosure about investor engagement activities and does not involve any financial results, business decision, or material change. Stock price is unlikely to be directly impacted, though outcomes or views shared in these meetings can sometimes influence institutional investor interest.